Soetikno, Vivian <br/><br/>
Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.  [electronic resource] 

 -  Molecular nutrition & food research  Nov 2011 
 - 1655-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1613-4133 
<br/><br/><label>Standard No.: </label>10.1002/mnfr.201100080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--therapeutic use<br/>Curcumin--therapeutic use<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetic Nephropathies--metabolism<br/>Extracellular Matrix Proteins--genetics<br/>Gene Expression Regulation--drug effects<br/>Isoenzymes--antagonists & inhibitors<br/>Kidney--drug effects<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>NADPH Oxidase 4<br/>NADPH Oxidases--metabolism<br/>Oxidative Stress--drug effects<br/>Phosphoproteins--metabolism<br/>Protein Kinase C--antagonists & inhibitors<br/>Protein Kinase C beta<br/>Protein Kinase C-alpha--antagonists & inhibitors<br/>Protein Kinase Inhibitors--therapeutic use<br/>RNA, Messenger--metabolism<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Streptozocin